News

15 May 2025

PExA to showcase non-invasive lung research platform and present at Respiratory Innovation Summit during ATS 2025

PExA AB, a Swedish life science company and pioneer in non-invasive lung research, will participate in the American Thoracic Society (ATS) 2025 International Conference, taking place May 16–21 in San Francisco, California.  Returning for the third consecutive year, PExA will exhibit at ATS — the world’s leading event for pulmonary, critical care, and sleep medicine. At Booth…

Read more
06 May 2025

PExA takes the next step — sharpening focus on clinical applications in lung diagnostics

PExA AB, a Swedish life science company and pioneer in non-invasive lung research, today announces a refined strategic direction to translate scientific advances into clinical solutions for early diagnosis and treatment monitoring of lung diseases. In recent years, PExA has focused on advancing its method and leveraging major developments in biochemical analysis. These advances have…

Read more
01 Apr 2025

Aarhus University upgrades its PExA instrument – continued trust in groundbreaking lung research

Aarhus University and Professor Torben Sigsgaard at the Department of Public Health have decided to upgrade their existing PExA 2.0 instrument to the latest version, PExA 2.1. The university is a long-standing user of PExA technology and has, since the initial installation in 2018, integrated it into their advanced research on how environmental factors affect…

Read more
28 Mar 2025

New research from Lund University may expand the donor lung pool for transplantation

A new scientific publication from Professor Sandra Lindstedt and her research team at Lund University highlights innovative strategies to improve lung transplantation through an in-depth analysis of molecular and functional responses to different types of lung injury. The study, recently published in Transplantation, explores how three distinct models of lung injury affect donor lungs and…

Read more
05 Mar 2025

PExA strengthens IP portfolio with European Patent Office’s “Intention to Grant” for non-invasive analysis of small airway particles during medical ventilation

PExA AB today announced that the European Patent Office (EPO) has issued an “Intention to Grant” for the company’s patent application covering its pioneering solution for non-invasive analysis of small airway particles in ventilated patients. This patent covers a device and method for analyzing exhaled particles to assess lung function during mechanical ventilation. The solution…

Read more

Archive

Categories